{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        825, 
        839
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1392, 
        1415
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        876, 
        896
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        740, 
        767
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        769, 
        774
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        497, 
        532
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        591, 
        617
      ]
    }
  ], 
  "Positive Findings Phraseology (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        841, 
        846
      ]
    }
  ], 
  "Primary Origin of Neoplasm (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        847, 
        859
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        775, 
        780
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1053014^CLIA|eMARCPlus|TN Cancer Registry|20170915000105||ORU^R01^ORU_R01|201709150001050001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-CY-001545^PathSys^44D1053014^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170831000000|||||||20170831000000|&FNA Interpretation and Report,|1801973490^^^^^^MD^^CMS^D^^^NPI||||||20170905000000|||F||||||C34.01^Malignant neoplasm of right main bronchus^I10|1083715031&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.microscopic examination\n\nDirect smear and cell block preparations are examined.\n\n\nPath report.site of origin\n\nFNA Right Hilar Mass   2 unstained slides received in fixative   30 mls of red fluid with material received in CytoLyt\n\n\nPath report.final diagnosis\n\nRight hilar mass, EBUS-guided fine needle aspiration:   Adenocarcinoma, favor lung primary. See comment.\n\n\nPath report.comments\n\nComments - The specimen demonstrates malignant epithelial cells consistent with adenocarcinoma. The cell block preparation contains relatively few atypical cells for immunohistochemical study, which are positive for antibody to TTF-1 and negative for GATA3. These results favor a primary lung carcinoma over metastasis from the patient's previous breast primary. Given the paucity of the cells for immunohistochemical studies, recommend careful correlation with clinical and imaging studies.\n\n\nPath report.relevant Hx\n\nHistory - Right hilar mass; History of breast cancer **Perform ER/PR; Her 2 neu if breast/rule out lung primary**\n\n\n"
}